Checked
Class IDrug recallTerminated
Finasteride Plus 1.25 mg Capsule recall
Recalled by MasterPharm LLC of South Richmond Hill, NY · FDA report 05/20/2020
Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.
- Class
- Class I
- Most serious
- Status
- Terminated
- Closed 09/07/2023
- Recall started
- 04/14/2020
- Distribution
- Nationwide
Reason for recall
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Class I: A reasonable chance that using or being exposed to the product will cause serious health problems or death.
Recalled product
- Product
- Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
- Lot and code info
- Lot #02-27-2020:04@11, Exp. August 25, 2020.
- Quantity
- 7260 capsules
- Recall number
- D-1269-2020
- Event ID
- 85619
- Initiated by
- Voluntary: Firm initiated
Where it was distributed
Nationwide in the U.S.
- Nationwide
Recall timeline
- 04/14/2020Firm started the recall
- 05/19/2020FDA classified it as Class I
- 05/20/2020Published in the FDA enforcement report
- 09/07/2023FDA closed (terminated) the recall
More recalls from MasterPharm
- Class IIDrug08/05/2020Calcium citrate tetrahydrate USP powder, 100 gm container, MasterPharm, 115-02 Liberty Ave, Richmond Hill...MasterPharm LLC · 26 products · Lack of Processing Controls (lack of assurance of conformity to...
- Class IDrug07/08/2020Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug...MasterPharm LLC · Super-potent Drug: This recall has been initiated due to the...
Frequently asked questions
- Why was Finasteride Plus 1.25 mg Capsule recalled?
- Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
- What does Class I mean?
- Class I is FDA's most serious recall category: a reasonable chance that using or being exposed to the product will cause serious health problems or death.
- Where was the recalled product sold?
- Nationwide in the U.S.
- Is this recall still active?
- The FDA lists the recall as terminated (closed 09/07/2023). FDA has determined the recall is complete and closed it.
Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 05/20/2020 · Do not rely on openFDA to make decisions regarding medical care